PROGNOSTIC VALUE OF THE 3Q27 AND 18Q21 TRANSLOCATIONS FOR DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA IN THE RITUXIMAB ERA

被引：0
|
作者：
Watanabe, R. [1 ]
Tomita, N. [1 ]
Matsumoto, C. [2 ]
Hattori, Y. [3 ]
Matsuura, S. [4 ]
Takasaki, H. [5 ]
Hashimoto, C. [6 ]
Fujita, H. [1 ]
Fujisawa, S. [7 ]
Ishigatsubo, Y. [1 ]
机构：
[1] Yokohama City Univ, Dept Internal Med & Clin Immunol, Grad Sch Med, Yokohama, Kanagawa 232, Japan
[2] Yokosuka City Hosp, Dept Hematol, Yokosuka, Kanagawa, Japan
[3] Fujisawa City Hosp, Dept Hematol, Fujisawa, Kanagawa, Japan
[4] Shizuoka Red Cross Hosp, Dept Hematol, Shizuoka, Japan
[5] Kanagawa Canc Ctr, Dept Oncol, Yokohama, Kanagawa 2410815, Japan
[6] Yamato Municipal Hosp, Dept Hematol, Yamato, Japan
[7] Yokohama City Univ, Dept Hematol, Med Ctr, Yokohama, Kanagawa 232, Japan
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：150 / 150
页数：1
相关论文
共 50 条
  • [21] The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
    Kobayashi, T.
    Kuroda, J.
    Yokota, I.
    Tanba, K.
    Fujino, T.
    Kuwahara, S.
    Isa, R.
    Yamaguchi, J.
    Kawata, E.
    Akaogi, T.
    Uchiyama, H.
    Kaneko, H.
    Uoshima, N.
    Kobayashi, Y.
    Teramukai, S.
    Taniwaki, M.
    BLOOD CANCER JOURNAL, 2016, 6 : e383 - e383
  • [22] Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era
    Yu-Chung Huang
    Chun-Yu Liu
    Hsueh-Ju Lu
    Han-Tsung Liu
    Man-Hsin Hung
    Ying-Chung Hong
    Liang-Tsai Hsiao
    Jyh-Pyng Gau
    Jin-Hwang Liu
    Hui-Chi Hsu
    Tzeon-Jye Chiou
    Po-Min Chen
    Cheng-Hwai Tzeng
    Yuan-Bin Yu
    Annals of Hematology, 2013, 92 : 1513 - 1520
  • [23] Diffuse large B cell lymphoma: prognostic factors in the rituximab era
    Guevara Arismendy, Natalia Maria
    Jaramillo Arbelaez, Patricia Elena
    Gaviria Jaramillo, Lina Maria
    IATREIA, 2013, 26 (03) : 302 - 312
  • [24] Caspase 3a: new prognostic marker for diffuse large B-cell lymphoma in the rituximab era
    Provencio, Mariano
    Martin, Paloma
    Garcia, Vanesa
    Candia, Antonio
    Sanchez, Antonio C.
    Bellas, Carmen
    LEUKEMIA & LYMPHOMA, 2010, 51 (11) : 2021 - 2030
  • [25] CLONING OF BCL-6, THE LOCUS INVOLVED IN CHROMOSOME TRANSLOCATIONS AFFECTING BAND 3Q27 IN B-CELL LYMPHOMA
    YE, BHH
    RAO, PH
    CHAGANTI, RSK
    DALLAFAVERA, R
    CANCER RESEARCH, 1993, 53 (12) : 2732 - 2735
  • [26] Follicular lymphoma grade 3B includes three cytogenetically defined subgroups with primary t(14;18), 3q27 or other translocations: t(14;18) and 3q27 are mutually exclusive.
    van den Berg, E
    Bosga-Bouwer, A
    van Imhoff, GW
    Boonstra, R
    van der Veen, AY
    Haralamabieva, E
    van den Berg, A
    de Jong, B
    Krause, V
    Palmer, MC
    Kluin, P
    Poppema, S
    LEUKEMIA, 2003, 17 (03) : 685 - 685
  • [27] Outcomes of the transformation of follicular lymphoma to diffuse large B-cell lymphoma in the rituximab era: A population-based study
    Zheng, Wenshuai
    Liu, Mingjuan
    Guan, Lixun
    Wang, Shenyu
    CANCER MEDICINE, 2024, 13 (08):
  • [28] First Case of Diffuse Large B-Cell Lymphoma Subtype of Monomorphic Post-Transplant Lymphoproliferative Disorder With 3q27 Translocation
    Kim, Hyerim
    Kim, In-Suk
    Lee, Eun Yup
    Shin, Dong Hoon
    Cho, Su-Hee
    ANNALS OF LABORATORY MEDICINE, 2016, 36 (04) : 380 - 383
  • [29] Outcomes of Cardiac Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Al-Juhaishi, Taha
    Abu Zeinah, Ghaith
    Al-Kindi, Sadeer
    BLOOD, 2020, 136
  • [30] Primary breast diffuse large B-cell lymphoma in the era of rituximab
    Zhang, Na
    Cao, Caineng
    Zhu, Yuan
    Liu, Peng
    Liu, Luying
    Lu, Ke
    Luo, Jialin
    Zhou, Ning
    ONCOTARGETS AND THERAPY, 2016, 9 : 6093 - 6097
12345